MeSH Review:
Receptor Cross-Talk
- Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach. Lautrette, A., Li, S., Alili, R., Sunnarborg, S.W., Burtin, M., Lee, D.C., Friedlander, G., Terzi, F. Nat. Med. (2005)
- Overexpression of estrogen receptor in HTB 96 human osteosarcoma cells results in estrogen-induced growth inhibition and receptor cross talk. Watts, C.K., King, R.J. J. Bone Miner. Res. (1994)
- Angiotensin II AT(1) and AT(2) receptors contribute to maintain basal adrenomedullary norepinephrine synthesis and tyrosine hydroxylase transcription. Jezova, M., Armando, I., Bregonzio, C., Yu, Z.X., Qian, S., Ferrans, V.J., Imboden, H., Saavedra, J.M. Endocrinology (2003)
- Adenosine and opioid receptor-mediated cardioprotection in the rat: evidence for cross-talk between receptors. Peart, J.N., Gross, G.J. Am. J. Physiol. Heart Circ. Physiol. (2003)
- Dual signaling regulated by calcyon, a D1 dopamine receptor interacting protein. Lezcano, N., Mrzljak, L., Eubanks, S., Levenson, R., Goldman-Rakic, P., Bergson, C. Science (2000)
- Receptor synergy of interleukin-6 (IL-6) and insulin-like growth factor-I in myeloma cells that highly express IL-6 receptor alpha [corrected]. Abroun, S., Ishikawa, H., Tsuyama, N., Liu, S., Li, F.J., Otsuyama, K., Zheng, X., Obata, M., Kawano, M.M. Blood (2004)
- Interferon-alpha directly represses megakaryopoiesis by inhibiting thrombopoietin-induced signaling through induction of SOCS-1. Wang, Q., Miyakawa, Y., Fox, N., Kaushansky, K. Blood (2000)
- B cell receptor (BCR) cross-talk: CD40 engagement enhances BCR-induced ERK activation. Mizuno, T., Rothstein, T.L. J. Immunol. (2005)
- B cell receptor (BCR) cross-talk: IL-4 creates an alternate pathway for BCR-induced ERK activation that is phosphatidylinositol 3-kinase independent. Guo, B., Rothstein, T.L. J. Immunol. (2005)
- Angiotensin II type 1 receptor-EGF receptor cross-talk regulates ureteric bud branching morphogenesis. Yosypiv, I.V., Schroeder, M., El-Dahr, S.S. J. Am. Soc. Nephrol. (2006)
- Combination of 1alpha,25-dihydroxyvitamin D(3) with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling. Bernardi, R.J., Trump, D.L., Yu, W.D., McGuire, T.F., Hershberger, P.A., Johnson, C.S. Clin. Cancer Res. (2001)
- Sex hormone regulation of systemic endothelial and renal microvascular reactivity in type-2 diabetes: studies in gonadectomized and sham-operated Zucker diabetic rats. Ajayi, A.A., Ogungbade, G.O., Okorodudu, A.O. Eur. J. Clin. Invest. (2004)
- Human T cell activation by OKT3 is inhibited by a monoclonal antibody to CD44. Rothman, B.L., Blue, M.L., Kelley, K.A., Wunderlich, D., Mierz, D.V., Aune, T.M. J. Immunol. (1991)
- Adenosine A1 and A2A receptor cross-talk during ageing in the rat myocardium. Arosio, B., Perlini, S., Calabresi, C., Tozzi, R., Palladini, G., Ferrari, A.U., Vergani, C., Annoni, G. Exp. Gerontol. (2003)
- Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk? Kearn, C.S., Blake-Palmer, K., Daniel, E., Mackie, K., Glass, M. Mol. Pharmacol. (2005)
- Metabotropic glutamate receptor signalling in perirhinal cortical neurons. Harris, S.L., Cho, K., Bashir, Z.I., Molnar, E. Mol. Cell. Neurosci. (2004)
- Cholinergic and adrenergic modulation of the Ca2+ response to endothelin-1 in human ciliary muscle cells. Prasanna, G., Dibas, A.I., Yorio, T. Invest. Ophthalmol. Vis. Sci. (2000)
- PGE2 triggers recovery of transmucosal resistance via EP receptor cross talk in porcine ischemia-injured ileum. Blikslager, A.T., Pell, S.M., Young, K.M. Am. J. Physiol. Gastrointest. Liver Physiol. (2001)
- An EGF receptor inhibitor induces RAR-beta expression in breast and ovarian cancer cells. Grunt, T.W., Puckmair, K., Tomek, K., Kainz, B., Gaiger, A. Biochem. Biophys. Res. Commun. (2005)
- The thyrotropin receptor. Kohn, L.D., Shimura, H., Shimura, Y., Hidaka, A., Giuliani, C., Napolitano, G., Ohmori, M., Laglia, G., Saji, M. Vitam. Horm. (1995)
- Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer. Shou, J., Massarweh, S., Osborne, C.K., Wakeling, A.E., Ali, S., Weiss, H., Schiff, R. J. Natl. Cancer Inst. (2004)
- Cardiovascular responses mediated by protease-activated receptor-2 (PAR-2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR-2 or PAR-1. Damiano, B.P., Cheung, W.M., Santulli, R.J., Fung-Leung, W.P., Ngo, K., Ye, R.D., Darrow, A.L., Derian, C.K., de Garavilla, L., Andrade-Gordon, P. J. Pharmacol. Exp. Ther. (1999)
- Heparin-binding EGF-like growth factor expression increases selectively in bladder smooth muscle in response to lower urinary tract obstruction. Borer, J.G., Park, J.M., Atala, A., Nguyen, H.T., Adam, R.M., Retik, A.B., Freeman, M.R. Lab. Invest. (1999)
- Induction of remission in a patient with metastatic breast cancer refractory to trastuzumab and chemotherapy following treatment with gefitinib ('Iressa', ZD1839). Schneeweiss, A., Kolay, S., Aulmann, S., Von Minckwitz, G., Torode, J., Koehler, M., Bastert, G. Anticancer Drugs (2004)